# VASOPRESSIN

NDC: 51662-1314
Generic name: VASOPRESSIN
Labeler / Manufacturer: HF Acquisition Co LLC, DBA HealthFirst
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20181117

FDA application: NDA204485

## Active ingredients

- VASOPRESSIN, UNSPECIFIED: 20 [USP'U]/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51662-1314"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51662-1314
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7ae1c8c9-7d75-55a8-e053-2991aa0af05b